This company has been marked as potentially delisted and may not be actively trading. Miragen Therapeutics (MGEN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock MGEN vs. OPGN, NKTR, AVIR, SKIN, CATX, DSGN, ALT, DRUG, RXST, and TCMDShould you be buying Miragen Therapeutics stock or one of its competitors? The main competitors of Miragen Therapeutics include OpGen (OPGN), Nektar Therapeutics (NKTR), Atea Pharmaceuticals (AVIR), Beauty Health (SKIN), Perspective Therapeutics (CATX), Design Therapeutics (DSGN), Altimmune (ALT), Bright Minds Biosciences (DRUG), RxSight (RXST), and Tactile Systems Technology (TCMD). These companies are all part of the "medical" sector. Miragen Therapeutics vs. Its Competitors OpGen Nektar Therapeutics Atea Pharmaceuticals Beauty Health Perspective Therapeutics Design Therapeutics Altimmune Bright Minds Biosciences RxSight Tactile Systems Technology OpGen (NASDAQ:OPGN) and Miragen Therapeutics (NASDAQ:MGEN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership. Do insiders and institutionals have more ownership in OPGN or MGEN? 2.7% of OpGen shares are held by institutional investors. 43.8% of OpGen shares are held by company insiders. Comparatively, 1.1% of Miragen Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is OPGN or MGEN more profitable? OpGen has a net margin of -1,140.36% compared to Miragen Therapeutics' net margin of -1,393.50%. OpGen's return on equity of 0.00% beat Miragen Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets OpGen-1,140.36% N/A -287.58% Miragen Therapeutics -1,393.50%-141.66%-88.74% Does the media refer more to OPGN or MGEN? In the previous week, OpGen's average media sentiment score of 0.00 equaled Miragen Therapeutics'average media sentiment score. Company Overall Sentiment OpGen Neutral Miragen Therapeutics Neutral Which has more volatility and risk, OPGN or MGEN? OpGen has a beta of -1.77, suggesting that its share price is 277% less volatile than the S&P 500. Comparatively, Miragen Therapeutics has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500. Which has higher valuation & earnings, OPGN or MGEN? OpGen has higher earnings, but lower revenue than Miragen Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOpGen$2.67M0.00-$32.67MN/AN/AMiragen Therapeutics$4.46M16.85-$41.87M-$20.09-0.96 SummaryOpGen beats Miragen Therapeutics on 5 of the 9 factors compared between the two stocks. Get Miragen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGEN vs. The Competition Export to ExcelMetricMiragen TherapeuticsMedical Laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$75.13M$614.50K$5.76B$9.58BDividend YieldN/AN/A4.41%4.10%P/E Ratio-1.81N/A31.1026.05Price / Sales16.850.92433.22103.03Price / CashN/AN/A37.7358.48Price / Book2.840.119.536.61Net Income-$41.87M-$27.68M$3.26B$265.56M Miragen Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGENMiragen TherapeuticsN/A$19.23+6.7%N/A+17.5%$75.13M$4.46M-1.8145High Trading VolumeOPGNOpGenN/A$0.00-99.7%N/A-100.0%$1K$2.67M0.00100Gap DownNKTRNektar Therapeutics4.408 of 5 stars$23.60+5.0%$88.33+274.3%+49.5%$278.79M$98.43M-2.68220AVIRAtea Pharmaceuticals1.7908 of 5 stars$3.51flat$6.00+70.9%-3.2%$278.55MN/A-2.1870SKINBeauty Health1.0471 of 5 stars$2.32+5.0%$2.63+13.1%+46.4%$278.45M$334.30M-8.291,030Positive NewsCATXPerspective Therapeutics1.58 of 5 stars$3.98+7.0%$12.56+215.5%-75.4%$276.13MN/A0.0070Analyst RevisionDSGNDesign Therapeutics0.1605 of 5 stars$4.98+3.3%N/A+7.1%$274.49MN/A-4.4540ALTAltimmune3.2669 of 5 stars$3.62+7.1%$17.75+390.3%-47.6%$274.14M$20K-2.8750Trending NewsDRUGBright Minds Biosciences2.6964 of 5 stars$39.49+1.9%$83.25+110.8%+4,168.0%$272.95MN/A-109.69N/ATrending NewsAnalyst ForecastAnalyst RevisionRXSTRxSight1.0116 of 5 stars$7.35+10.5%$10.00+36.1%-82.9%$272.09M$139.93M-9.19220Trending NewsShort Interest ↑TCMDTactile Systems Technology2.6835 of 5 stars$12.57+3.3%$13.50+7.4%+6.2%$271.29M$298.85M20.271,037Positive News Related Companies and Tools Related Companies OpGen Alternatives Nektar Therapeutics Alternatives Atea Pharmaceuticals Alternatives Beauty Health Alternatives Perspective Therapeutics Alternatives Design Therapeutics Alternatives Altimmune Alternatives Bright Minds Biosciences Alternatives RxSight Alternatives Tactile Systems Technology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGEN) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Miragen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Miragen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access